Halozyme Therapeutics HALO Other receivable — Accounts receivable, net and contract assets
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableGrossCurrent.
The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's other receivable — accounts receivable, net and contract assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Halozyme Therapeutics's other receivable — accounts receivable, net and contract assets?
- Halozyme Therapeutics (HALO) reported other receivable — accounts receivable, net and contract assets of $0 in Q1 2026.
- What does other receivable — accounts receivable, net and contract assets mean?
- This metric represents the aggregate value of outstanding receivables and contract assets specifically attributed to the 'Other' business segment. It captures amounts owed to the company by customers for products or services delivered, adjusted for potential uncollectible accounts, alongside recognized revenue for performance obligations satisfied but not yet billed. This figure is critical for assessing the liquidity and credit quality of the revenue streams generated within this specific operational segment.